CD44 and breast carcinoma: To assess whether BPMNs can promote the migration of BCSCs, flow cytometry was used in ALDH1A1-FITC-stained or CD44-PerCP-Cyanine 5.5/CD24-PE-stained breast cancer cells obtained from the lower Transwell chambers.